There were also obviously decreased tumour weights in the ARHGAP5‐AS1‐KD group compared to the control group (Figure 2F), which is in support of the oncogenic role of ARHGAP5‐AS1 in HCC. Here, ARHGAP5 is linked to hepatocellular carcinoma.